The Lever: Pfizer’s Massive Tax Dodge

While jacking up drug prices, Pfizer recently reported more than $27 billion in revenue from its U.S. sales in 2023. But the Big Pharma titan owes nothing in federal income taxes, despite being one of the most profitable pharmaceutical companies in the world. That’s largely thanks to existing loopholes and a 2017 tax law signed by former President Donald Trump.

Read more. 

---